PharmaCyte Biotech, Inc. (NASDAQ:PMCB) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of series C convertible preferred stock and common stock purchase warrants Closed: US$7M raised · US$1,000 a share · Warrants at US$1 for 60 months · GP Nurmenkari Inc. Dealers: GP Nurmenkari Inc. (lead) Use of proceeds: Strengthen balance sheet to support ongoing business initiatives and strategic growth opportunities | Aug 20, 2025 |